ShareValue scores for ABBOTINDIA.NSE: Valuation 29, Quality 73, Growth 48, Health 56.

Abbott India Limited logo

ABBOTINDIA.NSE
NSE

Abbott India Limited

₹27,855.00(+0.25%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-5% to 9%
Valuation
29
Overvalued
Price vs Value
Quality
73
Strong
Business Strength
Growth
48
Moderate
Revenue & Earnings
Health
56
Moderate
Financial Stability
Momentum
40
Bearish
Price Trend

Company Details

About

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, neuro-psychiat, pain management, respiratory, hepatic, neuroscience, metabolics, gennext, and consumer care products. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited operates as a subsidiary of Abbott Capital India Limited.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026